Decision To Screen For Prostate Cancer Should Include Patients, ACS Panel Says
In Brief: Ozer, Comis Join Allegheny Cancer Centers; Two Cooperative Groups Under Same Roof
FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy
FDA To Regulate Products From Human Cells, Tissue
NCI Extramural Program: Advisors Approve Concepts For Diagnostic Imaging Trials Group
In Congress: specer, Harkin Pan re-Introduction Of Research Trust Fund
Trending Stories
- Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- ACOG says it will no longer accept federal funding
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death - The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”
